n-(2-isobutyl-3-(n'-hydroxycarbonylamido)propanoyl)-o-methyltyrosinemethylamide has been researched along with Ulcer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dickinson, RP; Fray, MJ; Huggins, JP; Occleston, NL | 1 |
1 other study(ies) available for n-(2-isobutyl-3-(n'-hydroxycarbonylamido)propanoyl)-o-methyltyrosinemethylamide and Ulcer
Article | Year |
---|---|
A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers.
Topics: Administration, Cutaneous; Animals; Caproates; Cell Movement; Cells, Cultured; Chronic Disease; Fibronectins; Gelatin; Humans; Keratinocytes; Male; Matrix Metalloproteinase 3; Matrix Metalloproteinase Inhibitors; Polycyclic Compounds; Protease Inhibitors; Rabbits; Skin; Skin Diseases; Stereoisomerism; Structure-Activity Relationship; Ulcer; Valine | 2003 |